Hepatitis B vaccination induces mucosal antibody responses in the female genital tract, indicating potential mechanisms of protection against infection

Samuel J. Simpson, Rebecca Wiggins, James Martin Fox, Jabu Mthethwa, Chun Cai, Charles John Nash Lacey

Research output: Contribution to journalArticlepeer-review


Vaccines against hepatitis B virus confer effective protection. ELISA was developed to test for specific antibodies in female genital tract secretions. Anti-HBs IgG and IgA were detected in the cervico-vaginal secretions of women following Hepatitis B vaccination, indicating a potential genital tract role for neutralising antibodies against sexually transmitted HBV.
Original languageEnglish
JournalSexually transmitted diseases
Early online date16 Nov 2018
Publication statusE-pub ahead of print - 16 Nov 2018

Bibliographical note

© Copyright 2019 American Sexually Transmitted Diseases Association. This is an author-produced version of the published paper. Uploaded in accordance with the publisher’s self-archiving policy. Further copying may not be permitted; contact the publisher for details.

Cite this